Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03525743 · ClinicalTrials.gov registry record
Cardiac Output Monitoring in Critically Ill Patient Undergoing Intubation
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 28
- Enrollment target
NCT03525743: Completed study, sponsored by Mayo Clinic.
NCT03525743 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03525743 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
Collect hemodynamic data, such as heart rate, blood pressure, and cardiac output to help understand the effect of pre and post intubation.
Primary Outcome
change in cardiac output as measured in liters/minute
Interventions
- DEVICE NICOM (Non invasive cardiac output monitor)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-06-27 |
| Est. Completion | 2019-03-29 |
What the finished NCT03525743 record still lists
NCT03525743 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which NICOM (Non invasive cardiac output monitor) is the first listed.
NCT03525743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03525743 about?
NCT03525743 is a clinical study titled "Cardiac Output Monitoring in Critically Ill Patient Undergoing Intubation". Collect hemodynamic data, such as heart rate, blood pressure, and cardiac output to help understand the effect of pre and post intubation.
What is the current status of trial NCT03525743?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2018-06-27. Estimated completion is 2019-03-29.
What interventions are being tested in trial NCT03525743?
The interventions under investigation include: NICOM (Non invasive cardiac output monitor) (DEVICE).
Who is sponsoring clinical trial NCT03525743?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI